Your browser doesn't support javascript.
loading
Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases.
Ahtiainen, Maarit; Elomaa, Hanna; Väyrynen, Juha P; Wirta, Erkki-Ville; Kuopio, Teijo; Helminen, Olli; Seppälä, Toni T; Kellokumpu, Ilmo; Mecklin, Jukka-Pekka.
Afiliación
  • Ahtiainen M; Department of Education and Research, Hospital Nova of Central Finland, 40620 Jyväskylä, Finland.
  • Elomaa H; Department of Biological and Environmental Science, University of Jyväskylä, 40014 Jyväskylä, Finland.
  • Väyrynen JP; Department of Pathology, Hospital Nova of Central Finland, 40620 Jyväskylä, Finland.
  • Wirta EV; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, 90014 Oulu, Finland.
  • Kuopio T; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, 33520 Tampere, Finland.
  • Helminen O; Department of Education and Research, Hospital Nova of Central Finland, 40620 Jyväskylä, Finland.
  • Seppälä TT; Department of Biological and Environmental Science, University of Jyväskylä, 40014 Jyväskylä, Finland.
  • Kellokumpu I; Department of Pathology, Hospital Nova of Central Finland, 40620 Jyväskylä, Finland.
  • Mecklin JP; Surgery Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, 90014 Oulu, Finland.
Cancers (Basel) ; 13(7)2021 Mar 26.
Article en En | MEDLINE | ID: mdl-33810354
ABSTRACT

PURPOSE:

To evaluate immune cell infiltration, the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) expression and their prognostic value in a series of mismatch proficient (pMMR) CRC with matched liver and lung metastases.

METHODS:

Formalin-fixed paraffin-embedded tissue sections stained for CD3, CD8, PD-L1 and PD-1 from 113 primary CRC tumours with 105 liver and 59 lung metastases were analyzed. The amount of CD3 and CD8 positive lymphocytes were combined as immune cell score (ICS). Comparative analyses on immune contexture were performed both between the primary tumour and matched metastases and between the metastatic sites.

RESULTS:

In liver metastases, immune cell infiltration was increased in general compared to primary tumours but did not correlate case by case. On the contrary, ICS between lung metastases and primary tumours correlated well, but the expression of PD-1/PD-L1 was increased in lung metastases. The proportion of tumours with high ICS together with PD-L1-positivity almost doubled in metastases (39%) compared to primary tumours (20%). High ICS (compared to lowest) in patient's least immune-infiltrated metastasis was an independent prognostic marker for disease-specific (HR 9.14, 95%CI 2.81-29.68) and overall survival (HR 6.95, 95%CI 2.30-21.00).

CONCLUSIONS:

Our study confirms the prognostic value of high ICS in least immune-infiltrated metastases in pMMR CRC patients. Major differences observed in immune contexture between primary tumours and metastases may have significance for treatment strategies for patients with advanced CRC.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Finlandia